Persistent infection with oncogenic human papillomavirus (HPV) is a necessary causal
factor in the development of cervical cancer. Moreover, HPV, predominately type 16 and to a …

Persistent infection with oncogenic human papillomavirus (HPV) is a necessary cause of
cervical cancer. Moreover, HPV type 16 (and to a lesser degree HPV type 18) is linked with …

Opinion statement In the United States, there are 11,150 cases and 3670 deaths projected
due to invasive cervical cancer for 2007. Approximately 500,000 new cases and 274,000 …

Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …

Human papilloma virus (HPV) infections, which are common, produce epithelial lesions of
the nongenital and genital skin and mucous membranes. Although most infections are …

INTRODUCTION—Human papillomavirus (HPV) is a sexually transmitted pathogen that
causes anogenital and oropharyngeal disease in males and females. Persistent viral …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Persistent infection with one of the oncogenic human papillomavirus (HPV) types is a
necessity for the development of cervical cancer. By HPV vaccination, cervical cancer could …

Prophylactic human papillomavirus vaccine efficacy is almost too good to be true. The
benefits of herd immunity will, however, not be gained without high vaccine coverage. Here …

Since 2006, three vaccines against infections and disease caused by human papillomavirus
(HPV) became available in Europe—in 2006 a quadrivalent HPV 6/11/16/18 vaccine, in …